Product Code: GVR-4-68040-179-5
Animal Sedative Market Growth & Trends:
The global animal sedative market size is expected to reach USD 527.3 million by 2030 and is projected to grow at a CAGR of 5.71% over the forecast period, according to a new report by Grand View Research, Inc. The primary drivers of market growth include the rising prevalence of chronic diseases in animals, rising pet ownership, increasing number of surgical procedures, and increasing animal health expenditure. Furthermore, the rise in pet humanization has led to an expansion of veterinary services, including behavioral therapy and specialized treatments. Vets are more frequently prescribing sedatives for pets undergoing surgeries, dental procedures, and other medical interventions, contributing to market growth. In addition, pet insurance acceptability is increasing as a result of a number of causes, including pet humanization, expanding pet population, increased initiatives by major corporations, and rising veterinary care costs. The AVMA reports that pet owners are increasingly using pet insurance to help them pay for their pets' medical expenses.
There is a growing awareness about the importance of controlling the pet population to reduce the number of stray animals. This has led to an increase in the number of spaying procedures. Spaying, being a surgical procedure, requires anesthesia or sedatives to ensure the animal remains pain-free and immobile during the operation. As more pet owners bring their pets to veterinarians for spaying, the overall number of veterinary visits increases, driving the demand for veterinary pharmaceuticals, including sedatives. The use of sedatives in spaying dogs is an essential part of the veterinary procedure, ensuring the safety and comfort of the animal. For instance, according to an article published by Pangolia Pte. Ltd., in April 2024, in the United States, 85% of dogs have been neutered or spayed.
Moreover, global pet population growth is fueling the market growth. Over the past few years, the number of pets has increased drastically as more and more households have decided to adopt a pet to improve their quality of life. According to estimates from the Global Animal Health Association, the number of dogs in the United States alone is over 85 million. This association estimates that almost half a billion dogs and cats are owned by families in the United States, Europe, and China. In contrast, the country's dog and cat populations expanded dramatically between 2020 and 2022, as per the Canadian Animal Health Institute (CAHI). According to CAHI forecasts for 2022, the annual medicalization rate for dogs remained stable at 86%, while the medicalization rate for cats climbed by over 3%. This indicated that more pet cats visited veterinarians between 2020 and 2022. Therefore, the necessity for treating a variety of illnesses, such as arthritis in dogs and cats, rises along with the proportion of people who own pets.
Animal Sedative Market Report Highlights:
- Based on animal type, dogs held the dominant share of the market in 2023, as sedatives are more commonly used in dogs for several reasons.
- Based on route of administration, parenteral dominated the market in 2023. The parenteral route of administration provides a much quicker onset of action compared to oral sedatives.
- In terms of application, the surgical segment dominated the market in 2023. It is also anticipated to grow at the fastest CAGR over the forecast period. The rising number of surgeries in animals indeed plays a significant role in driving the demand for animal sedatives.
- In terms of end use, hospitals dominated the market with a share of over 53.00% in 2023. This can be attributed to the growing patient footfall in these hospitals to treat these diseases in animals.
- Based on drug class, Alpha-2 Adrenergic Receptor Agonists dominated the market in 2023. It is also anticipated to grow at the fastest CAGR over the forecast period.
- In 2023, North America held the largest revenue share of 38.57% in the market. The market is driven by the presence of established players and increasing demand for treatment among veterinary practices.
Table of Contents
Chapter 1. Methodology and Scope
- 1.1. Market Segmentation and Scope
- 1.2. Research Methodology
- 1.3. Information Procurement
- 1.3.1. Purchased Database
- 1.3.2. GVR's Internal Database
- 1.3.3. Secondary Sources
- 1.3.4. Primary Research
- 1.4. Information/Data Analysis
- 1.5. Market Formulation & Visualization
- 1.6. Data Validation & Publishing
- 1.7. Model Details
- 1.7.1. Commodity flow analysis
- 1.7.2. Global Market: CAGR Calculation
- 1.8. List of Secondary Sources
Chapter 2. Executive Summary
- 2.1. Market Outlook
- 2.2. Segment Outlook
- 2.3. Competitive Insights
Chapter 3. Animal Sedative Market Variable Trends & Scope
- 3.1. Market Lineage Outlook
- 3.1.1. Parent Market
- 3.1.2. Ancillary Market
- 3.2. Market Dynamics
- 3.2.1. Market Driver Analysis
- 3.2.1.1. Increasing Pet Ownership
- 3.2.1.2. Rising Prevalence Of Chronic Diseases In Animals
- 3.2.1.3. Increasing Animal Health Expenditure
- 3.2.1.4. Rising Surgical Procedures
- 3.2.2. Market Restraint Analysis
- 3.2.2.1. Stringent regulations
- 3.2.2.2. Side effects associated with sedatives
- 3.2.2.3. Lack of Skilled Professionals
- 3.2.3. Market Opportunity Analysis
- 3.2.4. Market Challenge Analysis
- 3.3. Animal Sedative Market Analysis Tools
- 3.3.1. Industry Analysis - Porter's
- 3.3.1.1. Bargaining power of suppliers
- 3.3.1.2. Bargaining power of buyers
- 3.3.1.3. Threat of substitution
- 3.3.1.4. Threat of new entrants
- 3.3.1.5. Competitive rivalry
- 3.3.2. PESTEL Analysis
- 3.3.2.1. Political & Legal landscape
- 3.3.2.2. Economic and Social landscape
- 3.3.2.3. Technological landscape
- 3.3.2.4. Environmental landscape
- 3.3.3. Regulatory Framework
- 3.3.4. Pricing Analysis
- 3.3.5. Estimated Animal Population, by key countries & Key species, 2023
- 3.3.6. COVID-19 Impact Analysis
Chapter 4. Animal Sedative Market: Animal Type Estimates & Trend Analysis
- 4.1. Segment Dashboard
- 4.2. Animal Sedative Market: Animal type Movement Analysis
- 4.3. Animal Sedative Market Size & Trend Analysis, by animal type, 2018 to 2030 (USD Million)
- 4.4. Dogs
- 4.4.1. Dogs Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
- 4.5. Cats
- 4.5.1. Cats Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
- 4.6. Horses
- 4.6.1. Horses Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
- 4.7. Others
- 4.7.1. Others Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
Chapter 5. Animal Sedative Market: By Drug Class Estimates & Trend Analysis
- 5.1. Segment Dashboard
- 5.2. Animal Sedative Market: By Drug Class Movement Analysis
- 5.3. Animal Sedative Market Size & Trend Analysis, by drug class, 2018 to 2030 (USD Million)
- 5.3.1. Phenothiazines
- 5.3.1.1. Phenothiazines Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
- 5.3.2. Benzodiazepines
- 5.3.2.1. Benzodiazepines Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
- 5.3.3. Alpha-2 Adrenergic Receptor Agonists
- 5.3.3.1. Alpha-2 Adrenergic Receptor Agonists Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
- 5.3.4. Butyrophenones
- 5.3.4.1. Butyrophenones Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
- 5.3.5. Others
- 5.3.5.1. Others Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
Chapter 6. Animal Sedative Market: By Application Estimates & Trend Analysis
- 6.1. Segment Dashboard
- 6.2. Animal Sedative Market: By Application Movement Analysis
- 6.3. Animal Sedative Market Size & Trend Analysis, by application, 2018 to 2030 (USD Million)
- 6.3.1. Surgical
- 6.3.1.1. Surgical Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
- 6.3.2. Diagnostic
- 6.3.2.1. Diagnostic Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
- 6.3.3. Others
- 6.3.3.1. Others Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
Chapter 7. Animal Sedative Market: By Route of Administration Estimates & Trend Analysis
- 7.1. Segment Dashboard
- 7.2. Animal Sedative Market: By Route of Administration Movement Analysis
- 7.3. Animal Sedative Market Size & Trend Analysis, by Route of Administration, 2018 to 2030 (USD Million)
- 7.3.1. Parenteral
- 7.3.1.1. Parenteral Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
- 7.3.2. Oral
- 7.3.2.1. Oral Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
Chapter 8. Animal Sedative Market: By End Use Estimates & Trend Analysis
- 8.1. Segment Dashboard
- 8.2. Animal Sedative Market: By End Use Movement Analysis
- 8.3. Animal Sedative Market Size & Trend Analysis, by End use, 2018 to 2030 (USD Million)
- 8.3.1. Hospitals
- 8.3.1.1. Hospitals Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
- 8.3.2. Specialty Centers
- 8.3.2.1. Specialty centers Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
- 8.3.3. Others
- 8.3.3.1. Others Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
Chapter 9. Animal Sedative Market: Regional Estimates & Trend Analysis
- 9.1. Regional Dashboard
- 9.2. Animal Sedative Market Share, By Region, 2023 & 2030 (USD Million)
- 9.3. Regional Outlook
- 9.4. North America
- 9.4.1. North America Animal Sedative Market Estimates And Forecasts, 2018 - 2030 (USD Million)
- 9.4.2. U.S.
- 9.4.2.1. Key Country Dynamics
- 9.4.2.2. U.S. Animal Sedative Market Estimates And Forecasts, 2018 - 2030 (USD Million)
- 9.4.3. Canada
- 9.4.3.1. Key Country Dynamics
- 9.4.3.2. Canada Animal Sedative Market Estimates And Forecasts, 2018 - 2030 (USD Million)
- 9.4.4. Mexico
- 9.4.4.1. Key Country Dynamics
- 9.4.4.2. Mexico Animal Sedative Market Estimates And Forecasts, 2018 - 2030 (USD Million)
- 9.5. Europe
- 9.5.1. Europe Animal Sedative Market Estimates And Forecasts, 2018 - 2030 (USD Million)
- 9.5.2. UK
- 9.5.2.1. Key Country Dynamics
- 9.5.2.2. UK Animal Sedative Market Estimates And Forecasts, 2018 - 2030 (USD Million)
- 9.5.3. Germany
- 9.5.3.1. Key Country Dynamics
- 9.5.3.2. Germany Animal Sedative Market Estimates And Forecasts, 2018 - 2030 (USD Million)
- 9.5.4. France
- 9.5.4.1. Key Country Dynamics
- 9.5.4.2. France Animal Sedative Market Estimates And Forecasts, 2018 - 2030 (USD Million)
- 9.5.5. Italy
- 9.5.5.1. Key Country Dynamics
- 9.5.5.2. Italy Animal Sedative Market Estimates And Forecasts, 2018 - 2030 (USD Million)
- 9.5.6. Spain
- 9.5.6.1. Key Country Dynamics
- 9.5.6.2. Spain Animal Sedative Market Estimates And Forecasts, 2018 - 2030 (USD Million)
- 9.5.7. Denmark
- 9.5.7.1. Key Country Dynamics
- 9.5.7.2. Denmark Animal Sedative Market Estimates And Forecasts, 2018 - 2030 (USD Million)
- 9.5.8. Sweden
- 9.5.8.1. Key Country Dynamics
- 9.5.8.2. Sweden Animal Sedative Market Estimates And Forecasts, 2018 - 2030 (USD Million)
- 9.5.9. Norway
- 9.5.9.1. Key Country Dynamics
- 9.5.9.2. Norway Animal Sedative Market Estimates And Forecasts, 2018 - 2030 (USD Million)
- 9.6. Asia Pacific
- 9.6.1. Asia Pacific Animal Sedative Market Estimates And Forecasts, 2018 - 2030 (USD Million)
- 9.6.2. Japan
- 9.6.2.1. Key Country Dynamics
- 9.6.2.2. Japan Animal Sedative Market Estimates And Forecasts, 2018 - 2030 (USD Million)
- 9.6.3. China
- 9.6.3.1. Key Country Dynamics
- 9.6.3.2. China Animal Sedative Market Estimates And Forecasts, 2018 - 2030 (USD Million)
- 9.6.4. India
- 9.6.4.1. Key Country Dynamics
- 9.6.4.2. India Animal Sedative Market Estimates And Forecasts, 2018 - 2030 (USD Million)
- 9.6.5. Australia
- 9.6.5.1. Key Country Dynamics
- 9.6.5.2. Australia Animal Sedative Market Estimates And Forecasts, 2018 - 2030 (USD Million)
- 9.6.6. South Korea
- 9.6.6.1. Key Country Dynamics
- 9.6.6.2. South Korea Animal Sedative Market Estimates And Forecasts, 2018 - 2030 (USD Million)
- 9.6.7. Thailand
- 9.6.7.1. Key Country Dynamics
- 9.6.7.2. Thailand Animal Sedative Market Estimates And Forecasts, 2018 - 2030 (USD Million)
- 9.7. Latin America
- 9.7.1. Latin America Animal Sedative Market Estimates And Forecasts, 2018 - 2030 (USD Million)
- 9.7.2. Brazil
- 9.7.2.1. Key Country Dynamics
- 9.7.2.2. Brazil Animal Sedative Market Estimates And Forecasts, 2018 - 2030 (USD Million)
- 9.7.3. Argentina
- 9.7.3.1. Key Country Dynamics
- 9.7.3.2. Argentina Animal Sedative Market Estimates And Forecasts, 2018 - 2030 (USD Million)
- 9.8. Middle East & Africa
- 9.8.1. Middle East & Africa Animal Sedative Market Estimates And Forecasts, 2018 - 2030 (USD Million)
- 9.8.2. South Africa
- 9.8.2.1. Key Country Dynamics
- 9.8.2.2. South Africa Animal Sedative Market Estimates And Forecasts, 2018 - 2030 (USD Million)
- 9.8.3. Saudi Arabia
- 9.8.3.1. Key Country Dynamics
- 9.8.3.2. Saudi Arabia Animal Sedative Market Estimates And Forecasts, 2018 - 2030 (USD Million)
- 9.8.4. UAE
- 9.8.4.1. Key Country Dynamics
- 9.8.4.2. UAE Animal Sedative Market Estimates And Forecasts, 2018 - 2030 (USD Million)
- 9.8.5. Kuwait
- 9.8.5.1. Key Country Dynamics
- 9.8.5.2. Kuwait Animal Sedative Market Estimates And Forecasts, 2018 - 2030 (USD Million)
Chapter 10. Competitive Landscape
- 10.1. Market Participant Categorization
- 10.2. Company Market Position Analysis/ Heap Map Analysis
- 10.3. Company Profiles
- 10.3.1. Zoetis Inc.
- 10.3.1.1. Participant's Overview
- 10.3.1.2. Financial Performance
- 10.3.1.3. Product Benchmarking
- 10.3.1.4. Strategic Initiatives
- 10.3.2. Virbac.
- 10.3.2.1. Participant's Overview
- 10.3.2.2. Financial Performance
- 10.3.2.3. Product Benchmarking
- 10.3.2.4. Strategic Initiatives
- 10.3.3. Ouro Fino Saude Animal Group
- 10.3.3.1. Participant's Overview
- 10.3.3.2. Financial Performance
- 10.3.3.3. Product Benchmarking
- 10.3.3.4. Strategic Initiatives
- 10.3.4. Dechra Pharmaceuticals Plc (EQT)
- 10.3.4.1. Participant's Overview
- 10.3.4.2. Financial Performance
- 10.3.4.3. Product Benchmarking
- 10.3.4.4. Strategic Initiatives
- 10.3.5. Merck & Co., Inc.
- 10.3.5.1. Participant's Overview
- 10.3.5.2. Financial Performance
- 10.3.5.3. Product Benchmarking
- 10.3.5.4. Strategic Initiatives
- 10.3.6. Bimeda Inc.
- 10.3.6.1. Participant's Overview
- 10.3.6.2. Financial Performance
- 10.3.6.3. Product Benchmarking
- 10.3.6.4. Strategic Initiatives
- 10.3.7. vetcar e.fi.
- 10.3.7.1. Participant's Overview
- 10.3.7.2. Financial Performance
- 10.3.7.3. Product Benchmarking
- 10.3.7.4. Strategic Initiatives
- 10.3.8. Chanelle Pharma (Exponent)
- 10.3.8.1. Participant's Overview
- 10.3.8.2. Financial Performance
- 10.3.8.3. Product Benchmarking
- 10.3.8.4. Strategic Initiatives
- 10.3.9. Randlab Australia Pty Ltd.
- 10.3.9.1. Participant's Overview
- 10.3.9.2. Financial Performance
- 10.3.9.3. Product Benchmarking
- 10.3.9.4. Strategic Initiatives
- 10.3.10. Troy Laboratories Pty Ltd
- 10.3.10.1. Participant's Overview
- 10.3.10.2. Financial Performance
- 10.3.10.3. Product Benchmarking
- 10.3.10.4. Strategic Initiatives
- 10.4. Strategy Mapping
- 10.4.1. Mergers & Acquisitions
- 10.4.2. Partnerships & Collaborations
- 10.4.3. Expansion
- 10.4.4. Product launch
- 10.4.5. Others
- 10.5. List of other Key players